Pfizer Inc. crushed Q2 estimates with a 36% EPS beat, proving its operational turnaround is gaining momentum. Click here to find out why PFE stock is a Buy.
Why The Market Is Dangerously Wrong About Pfizer Stock
view original post
Pfizer Inc. crushed Q2 estimates with a 36% EPS beat, proving its operational turnaround is gaining momentum. Click here to find out why PFE stock is a Buy.